Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine.
about
Advances in Molecular Diagnosis of HBV Infection and Drug ResistanceRescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus.Rapid and accurate genotyping of YMDD motif variants in the hepatitis B virus genome by an improved reverse dot blot method.Detection of mixed populations of wild-type and YMDD hepatitis B variants by pyrosequencing in acutely and chronically infected patients.Combinatorial RNA Interference Therapy Prevents Selection of Pre-existing HBV Variants in Human Liver Chimeric Mice.Evaluation of antiviral resistant hepatitis B virus subpopulations in patients with chronic hepatitis B by using terminal restriction fragment length polymorphism.Experience of anti-viral therapy in hepatitis B-associated membranous nephropathy, including Lamivudine-resistant strains.Lamivudine therapy for korean children with chronic hepatitis BQuasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach.Oligonucleotide chip for detection of Lamivudine-resistant hepatitis B virusComparison of sequence analysis and the INNO-LiPA HBV DR line probe assay for detection of lamivudine-resistant hepatitis B virus strains in patients under various clinical conditionsPrevalence of GBV-C among Iranian HBV positive patients using PCR-RFLP technique.Detection of hepatitis B virus in used razor blades by PCRDetection of YMDD mutants using universal template real-time PCR.Peptide nucleic acid array for detection of point mutations in hepatitis B virus associated with antiviral resistance.Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance.Quantitative detection of the M204V hepatitis B virus minor variants by amplification refractory mutation system real-time PCR combined with molecular beacon technology.
P2860
Q24810144-CB2E3954-23C8-4128-8FCC-A72D10350385Q33905600-FF660C58-D11D-4BA7-82AD-D167D7E6E023Q34143643-C7AE9851-D2A3-40B3-8A31-D91F19ABD4D7Q34294342-908F1000-DA01-4E31-8DF1-602B613C434CQ36181757-7B435315-A741-457D-B436-C37D88CD6238Q36330265-8F5764A2-A9FF-4FAD-B9E1-904A0F64FE72Q36485751-86FD0864-A0CC-4EF9-9EE5-DD7161941AEAQ37065689-C56F931D-2F12-411C-831E-B96FEB339984Q37285249-5A6F3F9C-B09E-4E15-A270-8B8D44463360Q37511150-B74BC79A-7B1A-4D16-B866-1A877F21A0FDQ39464720-15993AD3-B439-46E7-B24B-495710544FE3Q39492788-A70DF25F-9055-469C-9379-8EA101596C37Q40789613-FC80ED54-510A-4F68-9F1F-CED81217F66BQ41878007-6976B446-AE21-4A39-BAF0-04ADBD829F92Q42000973-DF683A0A-0058-484D-8974-003007EBA0C0Q42247961-0BD35C7C-4C31-4C9B-BBF0-3050B943DB9CQ43071697-7AD5BA3C-9DA0-4799-B546-5A88F21B4B37
P2860
Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Two sensitive PCR-based method ...... susceptibility to lamivudine.
@ast
Two sensitive PCR-based method ...... susceptibility to lamivudine.
@en
type
label
Two sensitive PCR-based method ...... susceptibility to lamivudine.
@ast
Two sensitive PCR-based method ...... susceptibility to lamivudine.
@en
prefLabel
Two sensitive PCR-based method ...... susceptibility to lamivudine.
@ast
Two sensitive PCR-based method ...... susceptibility to lamivudine.
@en
P2093
P2860
P1476
Two sensitive PCR-based method ...... susceptibility to lamivudine.
@en
P2093
Baldanti F
Carrick KM
Condreay LD
DesLauriers M
Gauthier J
P2860
P304
P407
P577
1999-10-01T00:00:00Z